Glenmark Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?
GLENMARK PHARMS has one hundred and twenty-two approved drugs.
There are eight tentative approvals on GLENMARK PHARMS drugs.
Summary for Glenmark Pharms
| US Patents: | 0 |
| Tradenames: | 101 |
| Ingredients: | 96 |
| NDAs: | 122 |
Drugs and US Patents for Glenmark Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharms | CALCIPOTRIENE | calcipotriene | CREAM;TOPICAL | 205772-001 | Jun 9, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Glenmark Pharms | CLOBETASOL PROPIONATE | clobetasol propionate | CREAM;TOPICAL | 209095-001 | May 10, 2018 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Glenmark Pharms Ltd | DIMETHYL FUMARATE | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 210309-001 | Oct 6, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
